Additional associations with metabolic disorders such as hyperglycemia (SV = 1.32), insulin resistance (SV = 1.20), and hypertriglyceridemia (SV = 1.13) further implicate TMEM64 in glucose and lipid metabolism (Supplementary Dataset 3). Here, TMEM64 is linked to hypertriglyceridemia.